Skip to content

Identification of Factors Causing Postoperative Cognitive Dysfunction in Patients Undergoing Cardiac Surgery With CPB

Identification of Factors Causing Postoperative Cognitive Dysfunction in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass (CPB)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03641833
Enrollment
130
Registered
2018-08-22
Start date
2018-08-02
Completion date
2021-09-30
Last updated
2018-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Cognitive Dysfunction

Keywords

cardiac, surgery, postoperative cognitive dysfunction, bypass, brain biomarkers, transcranial Doppler

Brief summary

The incidence of cognitive decline occurs in 53% of patients after cardiac surgery. Causes of POCD can be various: age, duration of cardiac bypass, medicaments and many others. The aim of this study is to determine factors causing postoperative cognitive dysfunction (POCD) and to identify which of them are most important

Detailed description

Prospective case-control study included patients undergoing cardiac at Clinic of Cardiac, Vascular and Thoracic Surgery, Lithuanian University of Health Sciences. Inclusion criteria is: 1) cardiac output \> 35%; 2) no agents affecting central nervous system; 3) no neuropathology; 5) no multiple organ dysfunction. Patients will have to perform mini mental state examination (MMSE), Trial making, addenbrooke tests before and 7 days after surgery. Brain biomarkers glial fibrillary acid protein (GFAP) and neurofilaments will be taken after induction, 24 and 48 hours after surgery. Transcranial Doppler will be performed to evaluate a.cerebri media blood flow speed during surgery. After these test, the investigators are going to examine data about patient and operation, recognize factors causing POCD and identify the most important of them.

Interventions

DIAGNOSTIC_TESTblood sample for brain biomarkers

Transcranial Doppler will be performed to evaluate a.cerebri media blood flow speed during surgery.

Sponsors

Rasa Bukauskiene
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Coronary artery bypass grafting or/and heart valve surgery; * Patients age\>18years * Cardiac output \>35%

Exclusion criteria

* Patient disagreement; * Diseases causing cognitive dysfunction; * Multi organic deficiency; * Agents affecting central nervous system

Design outcomes

Primary

MeasureTime frameDescription
Brain blood flow speed changes during surgery and correlation with POCD3 yearsTranscranial Doppler will be performed to evaluate a.cerebri media blood flow speed during surgery using the 2MHz TCD ultrasound transducer over the temporal area. By adjusting the probe the curve of arteria will appear. Target measurement- mean flow velocity (MFV is measured in cm/s).

Secondary

MeasureTime frameDescription
Brain biomarker GFAP concentration chances before and after surgery and correlation with POCD.3 yearsBlood sample for brain biomarkers GFAP will be taken after induction, 24 and 48 hours after surgery. GFAP concentration in blood serum is measured in ng/ml
Brain biomarker neurofilaments concentration chances before and after surgery and correlation with POCD.3 yearsBlood sample for brain biomarker neurofilaments will be taken after induction, 24 and 48 hours after surgery. GFAP concentration in blood serum is measured in pg/ml

Other

MeasureTime frameDescription
Determine factors causing POCD3 yearsPatients will complete questionares: mini mental state examination (MMSE), Trial making and addenbrooke test one day before and 10 days after the surgery. We are going to compare change in tests results after surgery and find correlation with brain biomarkers and blood flow speed during surgery

Countries

Lithuania

Contacts

Primary ContactRasa Bukauskiene
rasa.bukauskiene@lsmuni.lt867111033
Backup ContactEdmundas Sirvinskas, Professor
edmundas.sirvinskas@lsmuni.lt+37037326171

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026